According to the Asia Pacific Metabolic Testing Market Forecast Report, the market is valued at USD 85.70 million in 2022 and estimated to grow at a CAGR of 7.2%, to reach USD 121.32 million by 2027 during the forecast period 2022 to 2027.
The rise in the prevalence of lifestyle problems, rising healthcare spending, increased investments connected with the development of advanced technology, an increase in sedentary lifestyle, rise in R&D activities will significantly impact the Asia Pacific metabolic testing market's growth.
Furthermore, market growth is likely fueled by technology improvements and rising healthcare expenditures. As a result, the Asian regional segment is predicted to grow faster from 2020 to 2026 due to increased demand for better medical care, government initiatives, and healthcare awareness.
Furthermore, the market expansion is likely to be fueled by technological improvements such as the introduction of digital metabolic rate testing equipment and an aging population with a high risk of developing chronic diseases including cancer and kidney disorders and fast-rising healthcare spending levels during the forecast period.
Metabolism relates to the procedure of an enzyme converting a chemical into a product. Enzymes are vital in metabolism because they allow the organism to drive energy-producing processes. Technological advancements in metabolic testing have led to equipment such as CPET systems, metabolic carts, ECG/EKG attachable to CPET systems, and metabolic testing software for accurate and reliable results.
The high cost of equipment & software and reimbursement concerns would block market expansion and challenge the metabolic testing market. In addition, increased chances of misleading results due to a lack of well-trained personnel to do CMP testing and a strict regulatory environment are two significant restrictions on Asia pacific Metabolic Testing market growth.
This research report on the Asia Pacific Metabolic Testing Market has been segmented and sub-segmented into the following categories:
By Product:
By Application:
By Technology:
By End User:
By Country:
Geographically, APAC is predicted to see the most significant rise in market share throughout the forecast period despite having the smallest market share because of the need for excellent medical treatment, the standard of life, favorable government efforts, and patient awareness levels, Asia Pacific is expected to be the leading area in the global metabolic testing market in coming years.
The India Metabolic Testing Market is predicted to proliferate over the next five years due to the increased prevalence of diabetes and obesity, rising living standards, a larger patient pool, and improved healthcare infrastructure.
The China Metabolic Testing Market is expected to reach a decent CAGR due to the rise in demand for quality medical care, increasing disposable income and health care spending, growing awareness, and rising government initiatives driving regional markets.
The Australia Metabolic Testing Market is the fastest-growing market because of the increasing market consolidation, and new product releases are among the significant continuing trends. Furthermore, the overall regional market expansion is being driven by the rising usage of modern technologies in the metabolic testing market and the presence of well-established healthcare facilities.
KEY MARKET PLAYERS
Top companies dominating the APAC Metabolic Testing Market profiled in the report are Geratherm Medical AG (Germany), General Electric Company (U.S.), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), OSI Systems, Inc. (U.S.), Microlife Medical Home Solutions, Inc. (U.S.), Parvo Medics (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy).,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 CPET Systems
5.1.3 Metabolic Carts
5.1.4 ECG and EKG Systems
5.1.5 Body Composition Analyzers
5.1.6 Software
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 VO2 Max Analysis
5.2.3 RMR Analysis
5.2.4 Body Composition Analysis
5.2.5 Y-o-Y Growth Analysis, By Technology
5.2.6 Market Attractiveness Analysis, By Technology
5.2.7 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Lifestyle Diseases
5.3.3 Critical Care
5.3.4 Human Performance Testing
5.3.5 Dysmetabolic Syndrome X
5.3.6 Metabolic Disorders
5.3.7 Other Applications
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Laboratories
5.4.4 Sports Training Centers
5.4.5 GYMS
5.4.6 Other End Users
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Parvo Medics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Microlife Medical Home Solutions, Inc.
8.3 Korr Medical Technologies, Inc.
8.4 Cosmed
8.5 Cortex Biophysik GMBH
8.6 AEI Technologies, Inc.
8.7 OSI Systems, Inc.
8.8 MGC Diagnostics Corporation
8.9 Geratherm Medical AG
8.10 General Electric Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.